Search results

117 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
New findings from University of North Carolina-led HIV prevention study, HPTN 052
UNC researchers presented detailed data from the landmark HIV Prevention Trials Network (HPTN) 052 study today at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
Located in News / 2011 / July
New HIV call center will link patients to life-saving care
As we approach National HIV/AIDS Testing Day on June 27, a new call center will connect newly diagnosed North Carolinians with HIV care providers.
Located in News / 2013 / June
New study adds further guidance on when to start antiretroviral therapy for HIV
A new study led by researchers at the University of North Carolina at Chapel Hill finds that there may be a limit to how early the therapy, known as HAART, should start.
Located in News / 2011 / September
NIAID grant launches Kashuba's plan for HIV-prevention trials
Development of an AIDS vaccine is struggling. Topical treatments aimed at stopping HIV have made little progress. Angela Kashuba, PharmD, believes that antiretroviral drugs are the best hope for halting the spread of AIDS, especially in the developing world.
Located in Vital Signs / Archives / Vital Signs - Jan. 4, 2010
NIAID grant launches Kashuba's plan for HIV-prevention trials
Development of an AIDS vaccine is struggling. Topical treatments aimed at stopping HIV have made little progress. Angela Kashuba, PharmD, believes that antiretroviral drugs are the best hope for halting the spread of AIDS, especially in the developing world.
Located in Vital Signs / 2010 / Vital Signs - Jan. 4, 2010
Peter A. Leone, MD
Peter A. Leone, MD, is a professor in the Department of Medicine and is an expert in the diagnosis and treatment of sexually transmitted diseases.
Located in For the Media / Experts Guide
Pioneering study shows drug can purge dormant HIV
Researchers from the University of North Carolina at Chapel Hill have published pioneering research showing that a drug used to treat certain types of lymphoma was able to dislodge hidden virus in patients receiving treatment for HIV.
Located in News / 2012 / July
PrEP treatment prevented HIV transmission in humanized mice
Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.
Located in Vital Signs / 2010 / Vital Signs - Jan. 21, 2010
PrEP treatment prevented HIV transmission in humanized mice
Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.
Located in Vital Signs / Archives / Vital Signs - Jan. 21, 2010
Preventing HPV might lower risk of HIV infection in men
Men infected with human papillomavirus (HPV) are at greater risk of becoming infected with human immunodeficiency virus (HIV) than men who are not HPV positive, according to researchers at the University of North Carolina at Chapel Hill.
Located in Vital Signs / Archives / Vital Signs - May 13, 2010